Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B)
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 8, Pages 784
Publisher
MDPI AG
Online
2021-08-09
DOI
10.3390/ph14080784
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A patent review of topoisomerase I inhibitors (2016-present)
- (2021) Asier Selas et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anticancer and antiplasmodial activities
- (2020) Bhornrawin Akkachairin et al. BIOORGANIC CHEMISTRY
- Modification of 7-piperazinylquinolone antibacterials to promising anticancer lead compounds: Synthesis and in vitro studies
- (2019) Hamideh Ahadi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DNA Topoisomerases of Leishmania parasites; druggable targets for drug discovery
- (2018) Rosa Mª Reguer et al. CURRENT MEDICINAL CHEMISTRY
- Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation
- (2018) Ana Tejería et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity
- (2018) Concepción Alonso et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Leishmaniasis
- (2018) Sakib Burza et al. LANCET
- Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents
- (2018) Ana Tejería et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An overview of quinoline as a privileged scaffold in cancer drug discovery
- (2017) Robert Musiol Expert Opinion on Drug Discovery
- Study of the Hetero-[4+2]-Cycloaddition Reaction of Aldimines and Alkynes. Synthesis of 1,5-Naphthyridine and Isoindolone Derivatives
- (2017) Concepción Alonso et al. JOURNAL OF ORGANIC CHEMISTRY
- Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase
- (2016) Ana Tejería et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity
- (2016) Concepción Alonso et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An overview of molecular hybrids in drug discovery
- (2016) Gervais Bérubé Expert Opinion on Drug Discovery
- Synthesis and Biological Evaluation of 1,5-Naphthyridines as Topoisomerase I Inhibitors. A New Family of Antiproliferative Agents
- (2015) Concepcion Alonso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A review on anticancer potential of bioactive heterocycle quinoline
- (2015) Obaid Afzal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Infrared Fluorescent Imaging as a Potent Tool for In Vitro, Ex Vivo and In Vivo Models of Visceral Leishmaniasis
- (2015) Estefanía Calvo-Álvarez et al. PLoS Neglected Tropical Diseases
- Targeting DNA damage response in cancer therapy
- (2014) Noriko Hosoya et al. CANCER SCIENCE
- Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery
- (2014) Rafael Balaña-Fouce et al. International Journal for Parasitology-Drugs and Drug Resistance
- Advances in the development of hybrid anticancer drugs
- (2013) Sébastien Fortin et al. Expert Opinion on Drug Discovery
- Interfacial inhibitors: targeting macromolecular complexes
- (2011) Yves Pommier et al. NATURE REVIEWS DRUG DISCOVERY
- Structural studies of type I topoisomerases
- (2008) N. M. Baker et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started